JP2021525541A5 - - Google Patents

Info

Publication number
JP2021525541A5
JP2021525541A5 JP2020567958A JP2020567958A JP2021525541A5 JP 2021525541 A5 JP2021525541 A5 JP 2021525541A5 JP 2020567958 A JP2020567958 A JP 2020567958A JP 2020567958 A JP2020567958 A JP 2020567958A JP 2021525541 A5 JP2021525541 A5 JP 2021525541A5
Authority
JP
Japan
Prior art keywords
domain sequence
seq
positions
mutant cpf1
cpf1 endonuclease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020567958A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525541A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/064444 external-priority patent/WO2019233990A1/en
Publication of JP2021525541A publication Critical patent/JP2021525541A/ja
Publication of JP2021525541A5 publication Critical patent/JP2021525541A5/ja
Priority to JP2024226441A priority Critical patent/JP2025075025A/ja
Pending legal-status Critical Current

Links

JP2020567958A 2018-06-04 2019-06-04 変異体Cpf1エンドヌクレアーゼ Pending JP2021525541A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024226441A JP2025075025A (ja) 2018-06-04 2024-12-23 変異体Cpf1エンドヌクレアーゼ

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP18175707 2018-06-04
EP18175707.1 2018-06-04
EP18190950.8 2018-08-27
EP18190950 2018-08-27
PCT/EP2019/064444 WO2019233990A1 (en) 2018-06-04 2019-06-04 Mutant cpf1 endonucleases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024226441A Division JP2025075025A (ja) 2018-06-04 2024-12-23 変異体Cpf1エンドヌクレアーゼ

Publications (2)

Publication Number Publication Date
JP2021525541A JP2021525541A (ja) 2021-09-27
JP2021525541A5 true JP2021525541A5 (https=) 2022-07-05

Family

ID=66676556

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020567958A Pending JP2021525541A (ja) 2018-06-04 2019-06-04 変異体Cpf1エンドヌクレアーゼ
JP2024226441A Pending JP2025075025A (ja) 2018-06-04 2024-12-23 変異体Cpf1エンドヌクレアーゼ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024226441A Pending JP2025075025A (ja) 2018-06-04 2024-12-23 変異体Cpf1エンドヌクレアーゼ

Country Status (12)

Country Link
US (2) US12152257B2 (https=)
EP (1) EP3802806A1 (https=)
JP (2) JP2021525541A (https=)
KR (1) KR20210028163A (https=)
CN (1) CN112424349A (https=)
AU (1) AU2019282094A1 (https=)
BR (1) BR112020024736A2 (https=)
CA (1) CA3102676A1 (https=)
IL (1) IL279153A (https=)
MA (1) MA52739A (https=)
MX (1) MX2020013229A (https=)
WO (1) WO2019233990A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015330699B2 (en) 2014-10-10 2021-12-02 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
US11866726B2 (en) 2017-07-14 2024-01-09 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
EP3823633A4 (en) 2018-06-29 2023-05-03 Editas Medicine, Inc. SYNTHETIC LEAD MOLECULES, COMPOSITIONS AND METHODS RELATED THERETO
CN111521781B (zh) * 2020-02-24 2021-07-30 广州医科大学附属第一医院(广州呼吸中心) 一种用于新冠肺炎病毒SARS-CoV-2核酸的检测试剂盒及其检测方法
JP7850156B2 (ja) * 2020-12-17 2026-04-22 モンサント テクノロジー エルエルシー 操作されたssDNase不含CRISPRエンドヌクレアーゼ
EP4284923A1 (en) 2021-01-29 2023-12-06 Wageningen Universiteit Crispr-associated base-editing of the complementary strand
US20250025572A1 (en) * 2021-11-29 2025-01-23 Editas Medicine, Inc. Engineered crispr/cas12a effector proteins, and uses thereof
WO2023166030A1 (en) 2022-03-01 2023-09-07 BASF Agricultural Solutions Seed US LLC Cas12a nickases
JP2025511267A (ja) 2022-03-30 2025-04-15 ビーエーエスエフ アグリカルチュラル ソリューションズ シード ユーエス エルエルシー 最適化塩基エディター
AU2023380182A1 (en) 2022-11-18 2025-07-03 Kyoto Prefectural Public University Corporation Compositions for mitophagy induction and uses thereof
WO2024133272A1 (en) 2022-12-21 2024-06-27 BASF Agricultural Solutions Seed US LLC Increased editing efficiency by co-delivery of rnp with nucleic acid
US20250001010A1 (en) 2023-06-30 2025-01-02 Christiana Care Gene Editing Institute, Inc. Nras gene knockout for treatment of cancer
US20250319206A1 (en) 2024-04-04 2025-10-16 Christina Care Gene Editing Institute, Inc. Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2
WO2025226816A1 (en) 2024-04-23 2025-10-30 Christiana Care Gene Editing Institute, Inc. Methods of identifying and correlating crispr-induced exon skipping to phenotypic outcomes
CN119506249B (zh) * 2024-11-29 2025-11-07 大连理工大学 一种多PAM选择的基因编辑系统NovaCas-1及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9790490B2 (en) * 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
US10648020B2 (en) 2015-06-18 2020-05-12 The Broad Institute, Inc. CRISPR enzymes and systems
US20190048340A1 (en) * 2015-09-24 2019-02-14 Crispr Therapeutics Ag Novel family of rna-programmable endonucleases and their uses in genome editing and other applications
IL310721B2 (en) 2015-10-23 2025-11-01 Harvard College Nucleobase editors and uses thereof
US12110490B2 (en) * 2015-12-18 2024-10-08 The Broad Institute, Inc. CRISPR enzymes and systems
EP3445853A1 (en) 2016-04-19 2019-02-27 The Broad Institute, Inc. Cpf1 complexes with reduced indel activity
KR20260004568A (ko) 2016-04-19 2026-01-08 더 브로드 인스티튜트, 인코퍼레이티드 신규한 crispr 효소 및 시스템
CN106244591A (zh) * 2016-08-23 2016-12-21 苏州吉玛基因股份有限公司 修饰crRNA在CRISPR/Cpf1基因编辑系统中的应用
CN109790527A (zh) 2016-07-26 2019-05-21 通用医疗公司 普氏菌属和弗朗西斯氏菌属的CRISPR1(Cpf1)的变体
CN110214183A (zh) 2016-08-03 2019-09-06 哈佛大学的校长及成员们 腺苷核碱基编辑器及其用途
KR102622411B1 (ko) 2016-10-14 2024-01-10 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
SG10201913505WA (en) 2016-10-17 2020-02-27 Univ Nanyang Tech Truncated crispr-cas proteins for dna targeting
KR20240116572A (ko) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
WO2018195540A1 (en) 2017-04-21 2018-10-25 The General Hospital Corporation Inducible, tunable, and multiplex human gene regulation using crispr-cpf1
US11591589B2 (en) 2017-04-21 2023-02-28 The General Hospital Corporation Variants of Cpf1 (Cas12a) with altered PAM specificity
WO2018209014A1 (en) 2017-05-10 2018-11-15 Regents Of The University Of Minnesota Programmable transcription factors and methods
WO2018213726A1 (en) 2017-05-18 2018-11-22 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
US11866697B2 (en) 2017-05-18 2024-01-09 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
KR102655021B1 (ko) 2017-07-11 2024-04-04 시그마-알드리치 컴퍼니., 엘엘씨 표적된 게놈 변형을 개선하기 위한 뉴클레오솜 상호작용 단백질 도메인 사용
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
US11649442B2 (en) 2017-09-08 2023-05-16 The Regents Of The University Of California RNA-guided endonuclease fusion polypeptides and methods of use thereof
WO2019075197A1 (en) 2017-10-11 2019-04-18 The General Hospital Corporation METHODS OF DETECTION OF INDIVIDUAL SITE-SPECIFIC PARASITE GENOMIC DEAMINATION BY BASE EDITING TECHNOLOGIES
US20210079366A1 (en) 2017-12-22 2021-03-18 The Broad Institute, Inc. Cas12a systems, methods, and compositions for targeted rna base editing
US11884947B2 (en) 2018-02-23 2024-01-30 Shanghaitech University Fusion proteins for base editing
KR102287880B1 (ko) 2018-03-26 2021-08-09 고쿠리츠다이가쿠호진 고베다이가쿠 세포에서 이중 가닥 dna의 표적 부위를 변형시키기 위한 방법
KR102922694B1 (ko) 2018-04-19 2026-02-03 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 유전자 편집을 위한 조성물 및 방법

Similar Documents

Publication Publication Date Title
JP2021525541A5 (https=)
CN110139927B (zh) Crispr-cas9抑制剂
Loessner et al. Evidence for a holin-like protein gene fully embedded out of frame in the endolysin gene of Staphylococcus aureus bacteriophage 187
Zimmer et al. Genome and proteome of Listeria monocytogenes phage PSA: an unusual case for programmed+ 1 translational frameshifting in structural protein synthesis
US20230159927A1 (en) Chromatin remodelers to enhance targeted gene activation
JP2022522650A5 (https=)
Nambu et al. Peptidoglycan-hydrolyzing activity of the FlgJ protein, essential for flagellar rod formation in Salmonella typhimurium
FI3585910T3 (fi) Koostumukset ja menetelmät proteiinin tuotannon lisäämiseksi bacillus licheniformiksessa
JP2017018125A5 (https=)
WO2008035205A2 (en) Recombinase polymerase amplification
Fortier et al. Expression and site-directed mutagenesis of the lactococcal abortive phage infection protein AbiK
JP2021088567A5 (https=)
JP2008515450A5 (https=)
Zago et al. Characterization of the genome of the dairy Lactobacillus helveticus bacteriophage ΦAQ113
WO2024240053A1 (zh) 一种基因编辑蛋白、其相应的基因编辑系统及应用
JP2020127419A5 (https=)
Piazzolla et al. Expression of phage P4 integrase is regulated negatively by both Int and Vis
Sut et al. Protein and DNA effectors control the TraI conjugative helicase of plasmid R1
CN115786305A (zh) 一种紧凑型编辑工具EbCas12a在基因编辑中的应用
Chandry et al. Analysis of the cos region of the Lactococcus lactis bacteriophage sk 1
China et al. A transcript cleavage factor of Mycobacterium tuberculosis important for its survival
CN103881989A (zh) 一种具有持续合成能力和盐耐受度的新型dna聚合酶
CA2362518A1 (en) Heat-inducible promoter
US20230235306A1 (en) Argonaute protein from eukaryotes and application thereof
WO2018201010A1 (en) Method of off-target recording of spacer sequences within a cell in vivo